ArticleDiabetes, obesity & metabolism2025

Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference network.

Sophie Lamothe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.